abcdefghijklmn
opqrstuvwxyz
Test Menu
Test Change Details
Allergy & Immunology
Cardiology & Coagulation
Dermatopathology
Endocrinology
Gastroenterology
Genetics
Hepatology
Infectious Disease
Microbiology
Nephrology
Neurology
Oncology
Pathology
Pediatrics
Rheumatology
Toxicology
Urology
Women's Health
92052: Cardio Iq(r) Ascvd Risk Panel With Score Print View
Cholesterol, Total   < 20 years: 125 - 170
>= 20 years: 125 - 200 
mg/dL 
HDL Cholesterol   view ref range  mg/dL 
Triglycerides   view ref range  mg/dL 
LDL Chol, Calculated   < 2 years: Call Client Services
< 21 years: < 110
>= 21 years: < 130 
mg/dL 
Cholesterol/HDL Ratio   < 5.1  calc 
Non-HDL Cholesterol   < 20 years: < 120
>= 20 years: Call Client Services 
mg/dL 
10 Year ASCVD Risk     % 
10 Year ASCVD Risk Goal     % 
Lifetime ASCVD Risk     % 
African American      
Systolic Blood Pressure     mmHg 
Treatment for High B.P.      
Diabetes      
Current Smoker      

PRIMARY
1 Serum 2 (1) mL   Frozen - 15 Day(s)/Refrigerated - 7 Day(s)/Room Temperature - 48 Hour(s)  
ALTERNATE

ASCVD risk assessment using the ASCVD risk assessment calculation is currently recommended by 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk and 2013 ACC/AHA Blood Cholesterol Guidelines. There is a large body of evidence that the risk assessment and CHD prevention based on scores combining multiple risk factors is superior to those using single risk factors. Providing the ASCVD Risk assessment in the Cardio IQ lab report will simplify and improve risk assessment by physicians while helping to streamline the disease management decision process and improving clinical outcome.

The assay manufacturer, Roche, notes that N-acetylcysteine, when
administered in high concentrations (such as for treatment of
acetaminophen overdose), can interfere with their assay for HDL
cholesterol, leading to falsely low results.

For risk calculations to be performed, the following patient-specific
information have to be provided at the time of order:
Age: Years
Gender M (for male) or F (for female)
Race - African American: Y (for yes) or N (for no)
Systolic Blood Pressure: mmHg
Treatment for High Blood Pressure: Y (for yes) or N (for no)
Diabetes Status: Y (for yes) or N (for no)
Smoking Status: Y (for yes) or N (for no)
Patient should fast 9-12 hours prior to collection.
The assay manufacturer Beckman Coulter advises: "N-Acetyl Cysteine
(NAC), when administered in therapeutic concentrations (for the
treatment of acetaminophen overdose), has been...determined to
interfere with assays for...Cholesterol, Uric Acid" where "NAC
interference may lead to falsely low results." According to Beckman
Coulter, the NAC interference should be insignificant by 12 hours
after completion of the initial loading dose of an IV infusion
treatment regimen consisting of an initial loading dose of 150 mg/kg
administered over 1 hr a second dose of 50 mg/kg administered over 4
hrs and a third dose of 100 mg/kg administered over 16 hrs.
Setup Schedule
Monday-Friday

Reported (Analytical Time)
3 days

CPT Codes
82465,83718,84478

The CPT codes provided are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.

Notes
Reject Criteria: Gross hemolysis; moderate to gross icterus Transport Temperature: Refrigerated Methodology: Spectrophotometry, Enzymatic Additional Information If Triglyceride is >400 mg/dL, then Cardio IQ(R) Direct LDL, will be performed at an additional charge (CPT code(s) 83721).






1996 - 2017 Quest Diagnostics Nichols Institute of Valencia
For test information, please call Client Services at 800-421-4449.

San Francisco Web Design & Database